Porterhouse Medical Group

Porterhouse Medical Group is a global scientific and medical communications agency specializing in strategic healthcare communication solutions for biopharmaceutical and biotechnology companies worldwide[1][5][6]. It offers services such as medical writing, publication planning, market research and insights, creative services (including animations), event management (KOL encounters, advisory boards), health economics support, and more[3]. The group has particular expertise in rare diseases but works across multiple therapy areas. In July 2020 it was acquired by Integrated MedHealth Communication (imc group)[5]. The company supports commercialization of products by providing insight-driven communication strategies rather than developing its own pipeline of therapies. Its clients include pharmaceutical companies ranging from small to large organizations[3]. Headquarters are in Reading, UK with additional presence in the US[4][5]. There are no clinical results or drug development programs as it does not conduct R&D itself. As part of imc group post-acquisition, its capabilities have expanded further across North America and Europe[5].